FIELD: medicine, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition containing formoterol, budesonide, HFA 227, PVP (polyvinylpyrrolidone) taken in the concentration 0.001 wt.-% and PEG (polyethylene glycol) taken in the concentration 0.3 wt.-% wherein PVP represents PVP K25, and PEG represents PEG-1000. The composition is used in treatment of respiratory diseases. The composition possesses significantly decreased adverse effects based on low concentrations of accessory substances and high stability in storing.
EFFECT: improved and valuable properties of composition.
8 cl, 5 tbl, 16 dwg, 1 ex
